Search

everythinglearnresearchcommunity

for

Search:↓

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Androgenetic alopecia in women needs more research and better management strategies.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Hormonal birth control can cause skin issues, but low-dose options and those with antiandrogens may reduce these effects.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Low testosterone might be a common cause of hair loss in male dogs.

Review finds no permanent solution for female hair loss.

Review determines effective, safe treatments for female hair loss.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.